Here is what you need to know on Monday, October 5:
The coronavirus extended its claws to the White House. US President Trump announced on Friday that he and his wife Melania contracted COVID-19. As the day went by, the news reported that several of his advisor and staff members also caught the virus. Risk-off lead the way, helping the greenback to recover some ground. Nevertheless, the US currency ended the week with losses against all of its major rivals.
Trump’s health is the main theme ahead of the weekly opening. Weekend reports about his progress were contradictory, although Trump himself published a video late Saturday, indicating that he is feeling a bit better and that he continues to lead the country. The news few days will be critical, and headlines related to his health will likely trigger risk-sentiment related movements across the board.
On Friday, the US published the September monthly employment report, which showed that the country added a measly 661K new jobs, well below expected. The report fueled the dismal mood. The EUR/USD pair finished the day at around 1.1715, holding on to modest weekly gains.
The GBP/USD pair ended the week with substantial gains near 1.2978, amid hopes for a post-Brexit trade deal. Over the weekend, UK PM Boris Johnson and EU Commission President Ursula von der Leyen met and approved a further month of negotiations after agreeing progress has been made but "significant gaps" remain. Chief negotiators have been instructed to "work intensively" to close such gaps.
The USD/JPY pair traded alongside US Treasury yields, ending the week unchanged at around 105.40. Yields advanced, despite the risk-off mood that put equities under selling pressure.
Commodity-linked currencies were among the best performers, holding on to most of their weekly gains, despite falls in gold and crude oil. Gold flirted with 1,920 to settle at 1,890. WTI settled at $37.00 a barrel, its lowest settlement in three weeks.
Australia and China are on holidays at the beginning of the week, although the first will release some macroeconomic figures.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.